
Overview
Hassan Chami is a Pulmonary Medicine provider practicing medicine in Washington, Washington, D.c..
Dr. Chami is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Endoscopy.
Dr. Chami is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 1 clinical trial.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5215 Loughboro Road Northwest, Suite 420, Suite 420, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Inova Medical Group - Transplant Specialties
Schar Chair, Advanced Lung Disease and Lung Transplant Medical Director, Advanced Lung Disease and Lung Transplant Program, Inova Schar Heart and Vascular Professor of Medical Education, University of Virginia, Inova CampusSteven D. Nathan, MD, FCCP, is the medical director of Inova’s Advanced Lung Disease Program and Lung Transplant Program. He is also a professor of medicine at the University of Virginia.Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences. Dr. Nathan is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy.
Inova Schar Cancer Institute
Dr. Amit Mahajan is the Medical Director of interventional pulmonology at Inova Health System. He is board certified in interventional pulmonology, pulmonary medicine and critical care medicine. Dr. Mahajan completed his interventional pulmonology fellowship at Harvard Hospital System’s Interventional Pulmonology Program. Dr. Mahajan’s areas of expertise include procedures for diagnosing lung cancer, treating cancers within the airways, management of airway complications following lung transplantation, and bronchoscopic lung volume reduction (BLVR) for patients with severe emphysema. Additionally, Dr. Mahajan oversees Inova’s incidental lung nodule program and lung cancer screening program. Dr. Mahajan is nationally recognized as a leader in interventional pulmonology and has served on the board of directors for the American Association of Bronchoscopy and Interventional Pulmonology (AABIP) and the American Association of Respiratory Care (AARC). He has also been recognized as a Top Doctor for Washingtonian Magazine. Dr. Mahajan is a native of Toledo, OH, and currently resides in Vienna, VA, with his wife and three children. Dr. Mahajan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Lung Cancer, Advanced Bronchoscopy, and Endoscopy.
Inova Medical Group - Transplant Specialties
Shambhu Aryal, MD, FCCP, serves as Medical Director for the Inova Lung Transplant Program and Inova Sarcoidosis Center. He is board certified in internal medicine, pulmonology and critical care, with expertise in lung transplantation, sarcoidosis, interstitial lung diseases, pulmonary hypertension and bronchiectasis. Dr. Aryal joined Inova in 2017 with several years of clinical experience, immediately following an assistant professorship at Duke University Hospital. Dr. Aryal says that helping patients get a second chance at life is the most fulfilling aspect of transplant pulmonology. His expertise in advanced lung disease management and transplantation equips him to provide the best possible medical care to patients with severe lung diseases. Additionally, he has served as a clinical investigator for many clinical trials in his areas of expertise. Originally from Nepal, Dr. Aryal resides in Northern Virginia with his wife and two boys. He enjoys time with his family, watching his sons' soccer and basketball games, and traveling. Dr. Aryal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant.
Frequently Asked Questions about Dr. Hassan A. Chami
How do I make an appointment with Dr. Hassan A. Chami?
You can book an appointment with Dr. Hassan A. Chami by calling their office at 202-660-7509. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hassan A. Chami a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hassan A. Chami is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hassan A. Chami specialize in?
While Dr. Hassan A. Chami is a Pulmonary Medicine, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Hassan A. Chami participate in research or clinical trials?
Yes. Dr. Hassan A. Chami has published 42 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Hassan A. Chami's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hassan A. Chami accept my insurance?
Dr. Hassan A. Chami accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-660-7509 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Chami isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Chami isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Chami isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Chami isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaDr. Chami isExperienced. Learn about Acute Interstitial Pneumonia.
- BronchiectasisDr. Chami isExperienced. Learn about Bronchiectasis.
- Chronic Obstructive Pulmonary Disease (COPD)
- DrowsinessDr. Chami isExperienced. Learn about Drowsiness.
- EndoscopyDr. Chami isExperienced. Learn about Endoscopy.
- Excessive Daytime SleepinessDr. Chami isExperienced. Learn about Excessive Daytime Sleepiness.


